JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.96B |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.61B |
| 4 |
UnitedHealth
UNH
|
+$1.1B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.25B |
| 2 |
Centene
CNC
|
+$827M |
| 3 |
Amazon
AMZN
|
+$791M |
| 4 |
Texas Instruments
TXN
|
+$716M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$569M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.52% |
| 2 | Technology | 14.62% |
| 3 | Healthcare | 12.48% |
| 4 | Financials | 10.51% |
| 5 | Consumer Discretionary | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
iShares US Treasury Bond ETF
GOVT
$41.4B
| $2.2B | 0.32% |
96,803,143
+6,652,640
| +7% | +$158M |
2015 Q4
27 quarters
|
|
77
American Express
AXP
$208B
| $2.17B | 0.31% |
16,087,321
+540,816
| +3% | +$81.9M |
2013 Q2
37 quarters
|
|
78
Philip Morris
PM
$313B
| $2.17B | 0.31% |
26,098,403
+139,942
| +0.5% | +$13.3M |
2013 Q2
37 quarters
|
|
79
CALL
SPDR Gold Trust
GLD
$140B
| $2.12B | 0.31% |
13,736,700
+5,545,900
| +68% | +$892M |
2014 Q3
32 quarters
|
|
|
80
PUT
SPDR Gold Trust
GLD
$140B
| $2.03B | 0.29% |
13,110,200
-3,389,200
| -21% | -$545M |
2013 Q2
37 quarters
|
|
81
CALL
iShares S&P 100 ETF
OEF
$20.7B
| $2.03B | 0.29% |
31,094,800
+7,939,700
| +34% | +$1.44B |
2014 Q3
32 quarters
|
|
82
Merck
MRK
$351B
| $2.02B | 0.29% |
23,489,924
+760,074
| +3% | +$67.9M |
2013 Q2
37 quarters
|
|
83
Verizon
VZ
$193B
| $2.02B | 0.29% |
53,219,820
-771,702
| -1% | -$34.4M |
2013 Q2
37 quarters
|
|
84
Boston Scientific
BSX
$60.9B
| $1.96B | 0.28% |
50,639,607
-870,168
| -2% | -$34.9M |
2013 Q2
37 quarters
|
|
85
iShares MBS ETF
MBB
$35.6B
| $1.94B | 0.28% |
21,153,048
-4,085,616
| -16% | -$396M |
2013 Q2
37 quarters
|
|
86
US Bancorp
USB
$88.9B
| $1.88B | 0.27% |
46,627,305
+8,484,522
| +22% | +$393M |
2013 Q2
37 quarters
|
|
87
PPG Industries
PPG
$23.4B
| $1.87B | 0.27% |
16,912,062
-398,431
| -2% | -$49.2M |
2013 Q2
37 quarters
|
|
88
McKesson
MCK
$108B
| $1.87B | 0.27% |
5,503,963
-208,815
| -4% | -$72.5M |
2013 Q2
37 quarters
|
|
89
HDFC Bank
HDB
$113B
| $1.86B | 0.27% |
63,579,116
-2,462,830
| -4% | -$75.7M |
2013 Q2
37 quarters
|
|
90
Visa
V
$704B
| $1.85B | 0.27% |
10,418,905
+568,410
| +6% | +$116M |
2013 Q2
37 quarters
|
|
91
iShares Russell 1000 Value ETF
IWD
$82.2B
| $1.82B | 0.26% |
13,400,924
-1,084,931
| -7% | -$163M |
2013 Q2
37 quarters
|
|
|
92
iShares MSCI EAFE ETF
EFA
$75.9B
| $1.81B | 0.26% |
32,322,708
-9,128,026
| -22% | -$569M |
2013 Q2
37 quarters
|
|
93
Vanguard Short-Term Treasury ETF
VGSH
$34.5B
| $1.79B | 0.26% |
30,963,916
+196,574
| +0.6% | +$11.5M |
2018 Q3
16 quarters
|
|
|
94
Vanguard Intermediate-Term Treasury ETF
VGIT
$38.8B
| $1.79B | 0.26% |
30,630,217
+26,601,698
| +660% | +$1.61B |
2016 Q1
26 quarters
|
|
95
Accenture
ACN
$128B
| $1.74B | 0.25% |
6,755,339
+117,610
| +2% | +$34M |
2013 Q2
37 quarters
|
|
96
Pfizer
PFE
$159B
| $1.73B | 0.25% |
39,479,086
-1,552,889
| -4% | -$75.5M |
2013 Q2
37 quarters
|
|
97
Blackrock
BLK
$165B
| $1.73B | 0.25% |
3,136,042
-297,724
| -9% | -$195M |
2013 Q2
37 quarters
|
|
98
Air Products & Chemicals
APD
$62B
| $1.72B | 0.25% |
7,380,134
+989,651
| +15% | +$245M |
2013 Q2
37 quarters
|
|
99
Medtronic
MDT
$112B
| $1.71B | 0.25% |
21,131,719
+3,708,132
| +21% | +$333M |
2013 Q2
37 quarters
|
|
100
Northrop Grumman
NOC
$68.8B
| $1.69B | 0.24% |
3,582,672
-636,169
| -15% | -$303M |
2013 Q2
37 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2022 Portfolio in Review
As of Q3 2022, JP Morgan Chase held 7,216 positions worth $696B, down 3% from $718B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q3 2022 filing shows 556 new, 2,573 increased, 2,583 reduced and 516 closed positions. Its largest new stake was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2022 buy was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M.
- JP Morgan Chase added most to Invesco QQQ Trust in Q3 2022, an estimated $1.97B increase.
- JP Morgan Chase's biggest Q3 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $1.25B.
- JP Morgan Chase fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $248M.
- JP Morgan Chase's ten largest holdings make up 17% of its $696B portfolio in Q3 2022.
- JP Morgan Chase opened 556 new positions and closed 516 in Q3 2022.
- JP Morgan Chase's portfolio value fell 3% quarter-over-quarter to $696B.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.